Yext, Inc. Files Q2 FY2025 10-Q Report

TL;DR

Yext's Q2 FY2025 10-Q is in: check financials for latest performance.

AI Summary

Yext, Inc. filed its 10-Q for the period ending July 31, 2024. The company reported financial results for the second quarter of fiscal year 2025, detailing revenues, expenses, and net income. Specific financial figures and operational details for the period are available within the filing.

Why It Matters

This filing provides investors with Yext's latest financial performance and operational updates, crucial for understanding the company's current health and future prospects.

Risk Assessment

Risk Level: medium — 10-Q filings are standard financial reports, but the specific financial performance and market conditions detailed within can present varying levels of risk.

Key Players & Entities

• Yext, Inc. (company) — Filer of the 10-Q report
• 20240731 (date) — End of the reporting period
• 20240904 (date) — Filing date of the report

FAQ

Key Financial Figures

• $0.001 — ch registered Common Stock, par value $0.001 per share YEXT New York Stock Exchange

Filing Documents

• yext-20240731.htm (10-Q) — 1336KB
• q2fy25ex311sect302certceo.htm (EX-31.1) — 12KB
• q2fy25ex312sect302certcfo.htm (EX-31.2) — 12KB
• q2fy25ex321sect906certceo.htm (EX-32.1) — 6KB
• q2fy25ex322sect906certcfo.htm (EX-32.2) — 6KB
• yext-20240731_g1.jpg (GRAPHIC) — 29KB
• 0001614178-24-000104.txt ( ) — 5669KB
• yext-20240731.xsd (EX-101.SCH) — 31KB
• yext-20240731_cal.xml (EX-101.CAL) — 59KB
• yext-20240731_def.xml (EX-101.DEF) — 142KB
• yext-20240731_lab.xml (EX-101.LAB) — 530KB
• yext-20240731_pre.xml (EX-101.PRE) — 348KB
• yext-20240731_htm.xml (XML) — 589KB

Financial Statements

Financial Statements 6 Condensed Consolidated Balance Sheets ( U naudited) 6 Condensed Consolidated Statements of Operations and Comprehensive Loss ( U naudited) 7 Condensed Consolidated Statements of Stockholders' Equity ( U naudited) 8 Condensed Consolidated Statements of Cash Flows ( U naudited) 10 Notes to Condensed Consolidated Financial Statements 11 Item 2

Management's Discussion and Analysis of Financial Condition and Results of Operations

Management's Discussion and Analysis of Financial Condition and Results of Operations 19 Item 3

Quantitative and Qualitative Disclosures About Market Risk

Quantitative and Qualitative Disclosures About Market Risk 32 Item 4

Controls and Procedures

Controls and Procedures 33 PART II. OTHER INFORMATION Item 1

Legal Proceedings

Legal Proceedings 34 Item 1A

Risk Factors

Risk Factors 34 Item 2 Unregistered Sales of Equity Securities and Use of Proceeds 60 Item 3 Defaults Upon Senior Securities 60 Item 4 Mine Safety Disclosures 60 Item 5 Other Information 60 Item 6 Exhibits 61

SIGNATURES

SIGNATURES SPECIAL NOTE REGARDING FORWARD LOOKING STATEMENTS This Quarterly Report on Form 10-Q contains, and our officers and representatives may from time to time make, forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended (the "Securities Act"), and Section 21E of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), which statements involve substantial risks and uncertainties. All statements contained in this Quarterly Report on Form 10-Q other than statements of historical fact, including statements regarding our future results of operations and financial position, our business strategy and plans, and our objectives for future operations, are forward-looking statements. The words "believe," "may," "will," "potentially," "estimate," "continue," "anticipate," "plan," "intend," "could," "would," "expect," "possible," and similar expressions that convey uncertainty of future events or outcomes are intended to identify forward-looking statements. Forward-looking statements included in this Quarterly Report on Form 10-Q include, but are not limited to, statements regarding: our future revenue, cost of revenue, operating expenses and cash flows; anticipated trends, growth rates and challenges in our business and in the markets in which we operate; the effect of general macroeconomic conditions, including, but not limited to, the impact of foreign currency fluctuations, interest rates, inflation, recession risks and public health emergencies, such as the coronavirus ("COVID-19") pandemic, on our business, operations, and financial results and the business and operations of our customers and potential customers; our beliefs, objectives and strategies for future operations, including plans to invest in international expansion, research and development, and our sales and marketing teams, and the impact of such investments on our operations; changes in management and anticipated effects thereof; effe

FINANCIAL INFORMATION

PART I. FINANCIAL INFORMATION

Financial Statements

Item 1. Financial Statements YEXT, INC. Condensed Consolidated Balance Sheets (In thousands, except share and per share data) (Unaudited) July 31, 2024 January 31, 2024 Assets Current assets: Cash and cash equivalents $ 234,823 $ 210,184 Accounts receivable, net of allowances of $ 926 and $ 1,013 , respectively 45,870 108,198 Prepaid expenses and other current assets 18,312 14,849 Costs to obtain revenue contracts, current 23,048 26,680 Total current assets 322,053 359,911 Property and equipment, net 44,037 48,542 Operating lease right-of-use assets 71,872 75,989 Costs to obtain revenue contracts, non-current 12,793 16,710 Goodwill 4,478 4,478 Intangible assets, net 156 168 Other long term assets 2,815 3,012 Total assets $ 458,204 $ 508,810 Liabilities and stockholders' equity Current liabilities: Accounts payable, accrued expenses and other current liabilities $ 33,740 $ 38,766 Unearned revenue, current 156,194 212,210 Operating lease liabilities, current 17,574 16,798 Total current liabilities 207,508 267,774 Operating lease liabilities, non-current 83,201 89,562 Other long term liabilities 4,692 4,300 Total liabilities 295,401 361,636 Commitments and contingencies (Note 11) Stockholders' equity: Preferred stock, $ 0.001 par value per share; 50,000,000 shares authorized at July 31, 2024 and January 31, 2024; zero shares issued and outstanding at July 31, 2024 and January 31, 2024 — — Common stock, $ 0.001 par value per share; 500,000,000 shares authorized at July 31, 2024 and January 31, 2024; 150,518,464 and 148,197,347 shares issued at July 31, 2024 and January 31, 2024, respectively; 127,144,940 and 124,867,093 shares outstanding at July 31, 2024 and January 31, 2024, respectively 150 148 Additional paid-in capital 966,550 942,622 Accumulated other comprehensive loss ( 4,359 ) ( 4,183 ) Accumulated deficit ( 687,046 ) ( 679,172 ) Treasury stock, at cost ( 112,492 ) ( 112,241 ) Total stockhold

View Full Filing

View this 10-Q filing on SEC EDGAR